NCT03202303 Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) Status RECRUITING Phase PHASE2
NCT03134131 Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade Gliomas Status NO_LONGER_AVAILABLE Phase N/A
NCT03037203 A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness Status COMPLETED Phase PHASE2
NCT03030599 A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy Status COMPLETED Phase PHASE3
NCT02954887 Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7) Status COMPLETED Phase PHASE3
NCT02953548 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7) Status COMPLETED Phase PHASE3
NCT02892123 Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers Status COMPLETED Phase PHASE1
NCT02873338 Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT02863991 Oral ONC201 in Relapsed/Refractory Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT02851407 Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Status COMPLETED Phase PHASE3
NCT02806908 Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy Status COMPLETED Phase PHASE2
NCT02806895 Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA Status COMPLETED Phase PHASE2
NCT02769780 A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy Status COMPLETED Phase N/A
NCT02718755 Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies Status WITHDRAWN Phase PHASE2
NCT02660255 Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy Status APPROVED_FOR_MARKETING Phase N/A
NCT02647190 Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older Status WITHDRAWN Phase PHASE1
NCT02607904 An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy Status COMPLETED Phase PHASE2